Unknown

Dataset Information

Computational investigation of binding of chloroquinone and hydroxychloroquinone against PLPro of SARS-CoV-2.


ABSTRACT: Novel coronavirus SARS-CoV-2 has infected 18 million people with 700,000+ mortalities worldwide and this deadly numeric figure is rapidly rising. With very few success stories, the therapeutic targeting of this epidemic has been mainly attributed to main protease (Mpro), whilst Papain-like proteases (PLpro) also plays a vital role in the processing of replicase polyprotein. Multifunctional roles of PLpro such as viral polypeptide cleavage, de-ISGlyation and immune suppression have made it a promising drug target for therapeutic interventions. Whilst there have been a number of studies and others are on-going on repurposing and new-small molecule screening, albeit previously FDA approved drugs viz. Chloroquine (CQ) and Hydroxychloroquine (HCQ) have only been found effective against this pan

SUBMITTER: Patel D 

PROVIDER: S-EPMC7682385 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature